B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

Silmitasertib

0 PubMed studies analyzed

Similar Compounds by Shared Targets

The following compounds share molecular targets with Silmitasertib, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.

abemaciclib
26 shared targets
at
17 shared targets
k
23 shared targets
ruboxistaurin
27 shared targets
leucettamine
9 shared targets
rg
17 shared targets
crenolanib
18 shared targets
pf
20 shared targets
bms
21 shared targets
pi
13 shared targets
Loading evidence profile...

This evidence profile for Silmitasertib is generated deterministically from 0 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: v20260227-01. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.